MedPath

TMS for CRPS - Pilot Study

Not Applicable
Completed
Conditions
Complex Regional Pain Syndrome (CRPS)
Interventions
Device: Transcranial Magnetic Stimulation
Registration Number
NCT01926119
Lead Sponsor
Stanford University
Brief Summary

The purpose of this pilot study is to test whether Transcranial Magnetic Stimulation (TMS) may alleviate the symptoms of Complex Regional Pain Syndrome (CRPS). The investigators will test various methods of TMS in a small pilot study to investigate what methods may have clinical potential. This is a small pilot study to determine feasibility and signal to potentially inform future trials.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
4
Inclusion Criteria
  1. Age 18 or older
  2. Diagnosis of CRPS (complex regional pain syndrome)
  3. Average pain level reported on Numerical Rating Scale meets entry criteria
  4. Ability to perform the experimental task and procedures.
Read More
Exclusion Criteria
  1. MRI contraindication (metal implants or devices, claustrophobia)
  2. TMS Contraindication (eg metal implant or devices near the site of stimulation)
  3. History of epilepsy
  4. History of a psychological or psychiatric disorder that would interfere with study procedures, at the discretion of the researcher.
  5. Neurologic illness that would interfere with brain integrity
  6. Current medical condition or medication use that would interfere with study procedures or data integrity, at the discretion of the researcher.
  7. Currently pregnant or planning to become pregnant.
  8. On going legal action or disability claim.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
TMS Intervention - 5 daysTranscranial Magnetic StimulationApplication of Transcranial Magnetic Stimulation (TMS) once per day over 5 days.
Primary Outcome Measures
NameTimeMethod
Change in PainBaseline to post-TMS day 5

Numerical rating scale (NRS) where 0=no pain and 10=worst pain imaginable

Secondary Outcome Measures
NameTimeMethod
Change in Sudomotor FunctionEnd of each treatment session and at 1-week follow-up as compared to baseline
Change in Vasomotor FunctionEnd of each treatment session and at 1-week follow-up as compared to baseline
Change in Sensory PerceptionEnd of each treatment session and at 1-week follow-up as compared to baseline
Trophic ChangesEnd of each treatment session and at 1-week follow-up as compared to baseline
Change in Motor Function and CoordinationEnd of 5-day treatment series and at 1-week follow-up relative to baseline

As assessed by functional capacity exam and physical exam

Change in Motor Strength and Joint Range of MotionEnd of each of the 5 treatment sessions and at 1-week follow-up relative to baseline

Trial Locations

Locations (1)

Stanford University School of Medicine

🇺🇸

Palo Alto, California, United States

© Copyright 2025. All Rights Reserved by MedPath